Krystal Biotech says it's on schedule for filing for license with FDA By: Pittsburgh Business Times via Business Journals May 09, 2022 at 16:48 PM EDT "Our primary objective in 2022 is to prepare for the potential approval and launch of B-VEC in the U.S.," the company's CEO said. Read More >>
